Schonfeld Strategic Advisors LLC Verastem, Inc. Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$1.21 - $1.59 $33,029 - $43,402	-27,297 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.25 - $3.14 $34,121 - $85,712	27,297 New	27,297 $41,000
Q1 2019 May 15, 2019	SELL	$2.79 - $4.09 $316,450 - $463,900	-113,423 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.23 - $7.01 $366,356 - $795,095	113,423 New	113,423 $381,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.